Skip to main content
An official website of the United States government

Resources for News Media

The NCI press office is the central news contact for all members of the media. The office can assist you in arranging interviews with NCI researchers and in providing accurate and timely cancer research news and information.

For information about NCI's history and current activities, see NCI Overview and Budget and Appropriations.

Connect with Us

Our office hours are Monday through Friday, 9 a.m. to 5 p.m. ET.

Phone: 240-760-6600
Social Media:
NCI's YouTube Channel

Building 31, Room 10A25
31 Center Drive MSC 2580
Bethesda, MD 20892-2580

Recent Interviews from Scientists at NCI

From left to right, W. Kimryn Rathmell, M.D., Ph.D., M.M.H.C., Alice Chen Grady, M.D., Katrina A.B. Goddard, Ph.D., Wayne Lawrence, Dr.P.H., M.P.H, Philip E. Castle, Ph.D., M.P.H., and Shobha Srinivasan, Ph.D., Satish Gopal, M.D., M.P.H., Ophira Ginsburg, M.D., McCaskill-Stevens, Worta, M.D., M.S.

  • FDA approves self-collection screening for virus that causes cervical cancer

    May 15, 2024 | The Washington Post
    “The study will provide us the data to know what’s the uptake like, what do people do with this information? How is it received in different clinical settings, and do people engage with their gynecologists in a different way? And then ultimately, do we see a difference in cervical cancer cases?” NCI director Kimryn Rathmell said.

  • NIH’s New Cancer Screening Research Network and Cancer Screening Technologies

    May 10, 2024 | The ASCO Post
    “There are many cancers we still cannot reliably detect until it is so late that they become extremely difficult to treat,” said W. Kimryn Rathmell, MD, PhD, Director of the National Cancer Institute (NCI). “Emerging technologies such as multicancer detection tests could transform cancer screening and help to extend the lives of many more [patients]. We need to be sure these technologies work and understand how to use them, so they benefit everyone,” she emphasized.

  • NCI Director Discusses Cancer Moonshot In Interview.

    March 25, 2024 | The Nashville Post
    “Dr. W. Kimryn Rathmell earned her stripes while working at Vanderbilt University Medical Center. During her tenure as physician-in-chief and chair of the department of medicine, she was tapped to lead the National Cancer Institute in November.” As NCI director, “she will play an integral part in the White House’s Cancer Moonshot initiatives.” The Post interviewed Dr. Rathmell, who said, “I’m really excited about Cancer Moonshot because it signals that there’s significant White House support for cancer. Also, the Moonshot is an all-government approach. It means that we need to be talking to everybody about how we make a big difference for cancer.”

  • FDA approves groundbreaking treatment for advanced melanoma

    February 16, 2024 | NBC News
    The Food and Drug Administration approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated. The technology has been in development and studied for nearly 40 years. It was Rosenberg who pioneered TIL therapy — first describing how it could shrink melanoma tumors in the New England Journal of Medicine in 1988.

  • Cervical cancer is preventable, yet rising number of women in poor regions are getting it

    January 25, 2024 | USA Today
    Informing the public about treatment was also top of mind Thursday as the White House hosted a forum on cervical cancer, as part of the Biden administration’s cancer moonshot initiative, which aims to prevent more than 4 million cancer deaths by 2047. Dr. Kimryn Rathmell, the National Cancer Institute director, announced the availability of new at-home HPV testing. The trial program is set to begin in the second quarter of 2024 with 25 health institutions across the U.S.

  • W. Kimryn Rathmell, MD, PhD, Begins Work as 17th Director of the NCI

    December 19, 2023 | The ASCO Post
    On December 18, W. Kimryn Rathmell, MD, PhD, began her work as the 17th Director of the National Cancerl Institute (NCI). Dr. Rathmell was selected by President Biden to succeed Monica M. Bertagnolli, MD, FACS, FASCO, who left NCI to become the Director of the National Institutes of Health (NIH) on November 9.

  • Progress in childhood cancer has stalled for Blacks and Hispanics, report says

    November 16, 2023 | Associated Press
    The National Cancer Institute is working to gather data from every childhood cancer patient with the goal of linking each child to state-of-the-art care. The effort could improve equity, said Dr. Emily Tonorezos, who leads the institute’s work on cancer survivorship.

  • President Joe Biden Holds Ceremony For National Medal of Science and National Medal of Technology and Innovation Recipients

    October 24, 2023 | United Press International
    President Joe Biden awards Steven Rosenberg the National Medal of Technology and Innovation during a ceremony in the East Room of the White House in Washington, DC on Tuesday, October 24, 2023. The National Medal of Technology and Innovation recognizes individuals or teams for their technological contributions to America's economic, environmental and social well-being.

  • Study To Determine If 3D Mammograms Can Help Catch Advanced Breast Cancers Better Than 2D Imaging

    Oct. 17, 2023 | AP
    An article published by AP and reprinted in multiple outlets, including the Denver Post, focused on a clinical trial, TMIST, that is recruiting thousands of volunteers to try to find out if 3D mammography is better at detecting breast cancer.” The article featured an interview with NCI’s Dr. Worta McCaskill-Stevens who discussed this study and broader efforts to improve diversity in cancer research.

  • New study highlights systemic barriers to cancer treatment for women 

    Oct 14, 2023 | PBS News Hour, Weekend
    A recent international study revealed unique challenges facing women with cancer. Dr. Ophira Ginsburg, a senior advisor for Clinical Research at the National Cancer Institute's Center for Global Health, and one of the co-authors of the study was interviewed about this global effort.

  • Why Fighting Cancer In Low Income Countries Helps Progress In Rich Countries, Too

    Sept. 18, 2023 | Forbes
    Cancer should be addressed "as the global health emergency that it is," Dr. Satish Gopal, director of the U.S. National Cancer Institute's Center for global health shared with Forbes Editor-at-Large Russell Flannery in a video interview.

  • Experts Discuss Grail Blood Test For Cancer, Concerns Over Quality, Overtesting

    August 11, 2023 | KFF Health News
    An article published by KFF Health News and reprinted in multiple outlets, including the Philadelphia Inquirer, looked at “multi-cancer early-detection (MCED) tests, which analyze DNA fragments in the blood for abnormalities associated with cancer.” Among the experts interviewed was the National Cancer Institute Cancer Prevention Director Philip Castle.

  • NCI’s Shobha Srinivasan Discusses Agency’s Goal Of Improving Cancer Results For People In Poverty

    August 7, 2023 | Federal News Network
    Federal Drive with Tom Temin interviewed NCI Senior Advisor for Health Disparities Shobha Srinivasan about the details of the organization’s new grants. “Poverty often means less access to good health care, and therefore worse outcomes than those of the wealthy.” Now, the NCI “has awarded $50 million in grants to establish five new organizations devoted to cancer prevention and care.”

  • Dog cancer research advances pursuit of drugs for humans and canines

    June 20, 2023 | The Washington Post
    Compelling genetic data, increased funding and growing collaborations in the past decade are pushing forward development of cancer drugs for both canines and humans

  • NCI Program Explores Best Practices for Enrolling Underserved Groups to Precision Oncology Trials

    June 6, 2023 | Precision Medicine Online
    CHICAGO – A National Cancer Institute-funded study exploring strategies for diversifying clinical trials found community engagement, study navigators, and telemedicine showed promise in enrolling patients traditionally left out of research, but efforts to screen for and enlist study participants harboring specific biomarkers of interest weren't as successful.

  • New Blood Tests Offer Possible Early Detection of Cancer and Alzheimer’s

    April 19, 2023 | The Wall Street Journal
    New blood tests are taking on a growing role in early detection of such diseases as cancer and Alzheimer’s, among the most devastating health risks that emerge in aging. Using a single blood sample, one test released last year can detect early signals for more than 50 types of cancer, including some such as pancreatic cancer for which no routine preventive screening assays have existed up to this point. Other blood tests are proving accurate in detecting amyloid plaques—the proteins that clump together in the brains of Alzheimer’s patients.

Trending Topics

  • Multi-Cancer Detection (MCD) Research

    NCI has been studying biomarkers of cancer and cancer risk for more than 20 years. One outgrowth of this research has been combining the measures into a way to test for multiple kinds of cancer at the same time. These types of tests, which use blood, urine, or other body fluids, are collectively known as either Multi-Cancer Detection assays (MCDs) or sometimes Multi-Cancer Early Detection assays (MCEDs). NCI uses the term Multi-Cancer Detection (MCD) assays or MCD tests.

  • New NCI Director Eyes Cancer Moonshot, AI

    January 29, 2024 | Cancer Healthcast
    Dr. W. Kimryn Rathmell discusses her priorities ahead and how she views various tech innovation around cancer care and research. Dr. W. Kimryn Rathmell is one month into her post as National Cancer Institute’s new director and is already rolling up her sleeves on initiatives impacting health outcomes of cancer patients. Dr. Rathmell discusses her priorities for the year ahead, including a renewed focus on deepening connections across agencies, communities and the nation.

  • Financial Toxicity and Cancer Treatment (PDQ®)–Health Professional Version

    Financial Toxicity and Cancer Treatment discusses the increased financial distress that cancer patients and survivors uniquely experience. Get detailed information about the complex relationship between cancer and financial toxicity along with potential interventions in this clinician summary.

  • Cancer Moonshot Scholars

    The Cancer Moonshot Scholars program is designed to advance cancer science while also diversifying the pool of researchers and the approaches to cancer research that NCI funds. The program seeks to enhance the number of applications submitted by Early Stage Investigators from diverse backgrounds, including those from groups identified as underrepresented) in the biomedical, clinical, behavioral, and social sciences research workforce.

  • National Cancer Plan - Join Us

    People across the country and worldwide are counting on us to end cancer as we know it. Research alone will not accomplish this. To succeed, we must work together to develop strategies, share knowledge, and accelerate progress. The National Cancer Plan provides a comprehensive framework for this meaningful collaboration and unites us in acting on the vision President Biden and First Lady Biden set out in the Cancer Moonshot℠ to end cancer as we know it.

  • Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry

    Article on ScienceDirect - Background: Genetic factors play an important role in prostate cancer (PCa) susceptibility; Objective: To discover common genetic variants contributing to the risk of PCa in men of African ancestry.

  • White House Fact Sheet: On One Year Anniversary of Reignited Cancer Moonshot, Biden-⁠Harris Administration Announces New Actions to End Cancer as We Know It

    One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today.

  • HER2’s Genetic Link to Breast Cancer Spurs Development of New Treatments

    HER2 is a gene that has been linked to breast cancer growth. Learn about the development of trastuzumab, a monoclonal antibody that blocks the HER2 protein, and other treatments that have improved survival for women with HER2-positive breast cancer.

  • Cancer Treatment Vaccines

    Cancer treatment vaccines treat cancer by strengthening the body’s natural defenses against the cancer. This page covers how cancer treatment vaccines work against cancer, cancers that are treated with them, and the side effects they may cause.

  • NCI COVID-19 in Cancer Patients Study (NCCAPS)

    The NCI COVID-19 in Cancer Patients Study, or NCCAPS, is a natural history study of COVID-19 in people with cancer. The knowledge gained from this study will help doctors better manage treatment for people with cancer and COVID-19 in the future.

Multimedia from NCI

50 Years of Cancer Treatment and Diagnostics

Clinical trials, innovation in research, and technology have improved cancer treatment and diagnostics in public health. Listen to Healthcast’s National Cancer Act podcast series to learn more.


Recent News Releases